Senior insider sale
See Remarks at XERIS BIOPHARMA HOLDINGS, INC. — senior position signals high conviction
$1.61M
190K shares
What this filing means
MCCULLOCH KEVIN plans to sell 190K shares of XERIS BIOPHARMA HOLDINGS, INC. valued at approximately $1.61M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 9/28/2026ACC: 0001950047-26-009839
Officer· See Remarks
Since Mar 2026
190K
Shares to sell
$1.61M
Approx. market value
70K
Acquired (3 months)
1
Planned
3 completed
Securities Acquired — Last 3 Months1
Restricted Stock Units
N/A
1/31/2024
70KTotal acquired70K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/31/2024 | Restricted Stock Units N/A | 70K | — |
| Total | 70K | ||
Planned & Completed Dispositions4
Completed
—Completed
Units to sell
15K
Market value
$127.3K
9/1/2026
—Completed
Units to sell
15K
Market value
$120.2K
8/3/2026
—Completed
Units to sell
90K
Market value
$722.5K
7/1/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
70K
Market value
$637.0K
9/28/2026
Total
Units
190K
Value
$1.61M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
9/1/2026 | 15K | $127.3K | — | Completed |
8/3/2026 | 15K | $120.2K | — | Completed |
7/1/2026 | 90K | $722.5K | — | Completed |
| Planned — Approximate Date | ||||
9/28/2026 | 70K | $637.0K | NASDAQ | Planned |
| Total | 190K | $1.61M | ||